Declines in operating profit and net profit
First written in FY2019-Q1. 8 of 28 entries say "Restated". Latest entry: 2026-11-09.
Kaken Pharmaceutical moved to the "Worse" side of this theme in 2023, 1 year after the typical company in this theme (2022).
The whole theme swung hardest in 2023: 6 of 19 companies on the "Worse" side.
0 other companies' latest entry also says "Softened".
- FY2026WorsenedAnnual report
「The group's performance for the current consolidated fiscal year declined, with lower revenue and profit. Revenue was ¥76,871 million, down 18.3% year on year; the operating loss was ¥899 million, compared with operating profit of ¥21,034 million in the previous fiscal year; the ordinary loss was ¥206 million, compared with ordinary profit of ¥21,279 million; and net profit attributable to owners of the parent was ¥2,144 million, down 84.6%.」
Following higher revenue and profit driven by upfront contract payments and other factors in the previous fiscal year, revenue declined in the current fiscal year and the company posted an operating loss and an ordinary loss. Net profit also declined by 84.6%. - FY2026-H1WorsenedAnnual report
「The group's performance for the current interim consolidated accounting period declined, with lower revenue and profit. Revenue was ¥39,356 million, down 23.4% from the previous interim consolidated accounting period; operating profit was ¥203 million, down 99.0%; ordinary profit was ¥607 million, down 96.9%; and interim net profit attributable to owners of the parent was ¥992 million, down 93.0%.」
Performance changed from higher revenue and profit in the previous interim period to lower revenue and profit, with revenue, operating profit, ordinary profit and interim net profit attributable to owners of the parent all declining significantly. - FY2025-H1SoftenedAnnual report
「The group's performance for the current interim consolidated accounting period improved, with increases in both revenue and profit. Revenue was ¥51,372 million, up 42.0% from the previous interim consolidated accounting period; operating profit was ¥19,579 million, up 255.2%; ordinary profit was ¥19,823 million, up 246.4%; and interim net profit attributable to owners of the parent was ¥14,286 million, up 251.2%.」
Following the revenue and profit declines that continued through the previous fiscal year, revenue and profit both increased in the current interim consolidated accounting period. The company explained that upfront contract payments related to NM26 were the main factor behind the increases. - FY2024-Q3SoftenedAnnual report
「Revenue for the cumulative third quarter of the current fiscal year was ¥54,685 million, down 1.6% year on year, resulting in lower revenue. In terms of profit, mainly due to higher selling, general and administrative expenses, operating profit was ¥8,873 million, down 28.4%; ordinary profit was ¥9,304 million, down 28.3%; and net profit attributable to owners of the parent was ¥6,675 million, down 27.0%.」
Revenue and profit continued to decline, but the decline in operating profit narrowed from 32.8% in the previous quarter to 28.4%. - FY2024-Q2WorsenedAnnual report
「Revenue for the cumulative second quarter of the current fiscal year was ¥36,171 million, down 1.8% year on year, resulting in lower revenue. In terms of profit, mainly due to higher selling, general and administrative expenses, operating profit was ¥5,512 million, down 32.8%; ordinary profit was ¥5,722 million, down 33.1%; and net profit attributable to owners of the parent was ¥4,068 million, down 31.8%.」
Revenue and profit continued to decline, with the declines in operating profit, ordinary profit and net profit attributable to owners of the parent widening year on year. - FY2024-Q1WorsenedAnnual report
「In terms of profit, mainly due to higher selling, general and administrative expenses, operating profit was ¥3,293 million, down 18.8% year on year; ordinary profit was ¥3,488 million, down 19.5%; and net profit attributable to owners of the parent was ¥2,510 million, down 13.7%.」
The declines in operating profit and ordinary profit were 18.8% and 19.5% year on year, respectively, widening from the declines in the first quarter of the previous fiscal year. Net profit attributable to owners of the parent also declined, by 13.7%. - FY2023-Q3Steeper decline in operating profit and narrower decline in net profitAnnual report
「In terms of profit, due to lower revenue and higher selling, general and administrative expenses, among other factors, operating profit was ¥12,394 million, down 10.8% year on year; ordinary profit was ¥12,976 million, down 9.4%; and net profit attributable to owners of the parent was ¥9,149 million, down 10.7%.」
The decline in operating profit was 10.8% year on year, widening from the 9.2% decline in the cumulative second quarter of the previous fiscal year. Meanwhile, the decline in net profit attributable to owners of the parent was 10.7%, narrowing from the 11.3% decline in the cumulative second quarter of the previous fiscal year. - FY2023-Q2Steeper decline in operating profit and narrower decline in net profitAnnual report
「In terms of profit, due to lower revenue and higher selling, general and administrative expenses, among other factors, operating profit was ¥8,209 million, down 9.2% year on year; ordinary profit was ¥8,555 million, down 7.9%; and net profit attributable to owners of the parent was ¥5,964 million, down 11.3%.」
The decline in operating profit was 9.2% year on year, widening from the 8.3% decline in the first quarter of the previous fiscal year. Meanwhile, the decline in net profit attributable to owners of the parent was 11.3%, narrowing from the 13.5% decline in the first quarter of the previous fiscal year. - FY2023-Q1Narrower decline in operating profit and steeper decline in net profitAnnual report
「In terms of profit, due to lower revenue and higher selling, general and administrative expenses, among other factors, operating profit was ¥4,056 million, down 8.3% year on year; ordinary profit was ¥4,332 million, down 7.0%; and net profit attributable to owners of the parent was ¥2,907 million, down 13.5%.」
The decline in operating profit narrowed from 12.1% in the first quarter of the previous fiscal year to 8.3% year on year, while the decline in net profit attributable to owners of the parent widened from 12.0% to 13.5%. - FY2022Narrower decline in operating profit and steeper decline in net profitAnnual report
「In terms of profit, mainly due to higher selling, general and administrative expenses, operating profit was ¥17,064 million, down 4.1% year on year, and ordinary profit was ¥17,542 million, down 3.7%. Net profit attributable to owners of the parent was ¥9,549 million, down 28.8% year on year, due to extraordinary losses, including an impairment loss related to Lenabasam, a treatment for systemic sclerosis and dermatomyositis licensed from Corbus Pharmaceuticals.」
Operating profit and ordinary profit declined, but the declines narrowed from the previous quarter. Meanwhile, the decline in net profit attributable to owners of the parent widened to 28.8% due to impairment losses and other expenses related to Lenabasam. - FY2022-Q3SoftenedAnnual report
「In terms of profit, mainly due to higher selling, general and administrative expenses, operating profit was ¥13,889 million, down 7.1% year on year; ordinary profit was ¥14,322 million, down 6.7%; and net profit attributable to owners of the parent was ¥10,246 million, down 6.3%.」
Revenue increased, but profit continued to decline. However, the decline in operating profit narrowed from 7.6% in the cumulative second quarter of the previous fiscal year to 7.1%. - FY2022-Q2SoftenedAnnual report
「The group's performance for the cumulative second-quarter consolidated period was characterized by higher sales but lower profit. Operating profit declined 7.6% year on year to ¥9,036 million, ordinary profit declined 7.2% to ¥9,290 million, and quarterly net profit attributable to owners of the parent declined 7.0% to ¥6,721 million, mainly due to higher selling, general and administrative expenses.」
The operating profit decline narrowed from 12.1% year on year in the first quarter of the previous fiscal year to 7.6% in the cumulative second-quarter period. However, despite higher sales, operating profit, ordinary profit and net profit all fell below the same period of the previous year. - FY2022-Q1RestatedAnnual report
「The group's performance for the cumulative first-quarter consolidated period was characterized by higher sales but lower profit. Operating profit declined 12.1% year on year to ¥4,421 million, ordinary profit declined 11.2% to ¥4,660 million, and quarterly net profit attributable to owners of the parent declined 12.0% to ¥3,362 million, mainly due to higher selling, general and administrative expenses.」
Although net sales increased, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent all fell below the same period of the previous year. The performance profile changed from lower sales and lower profit in the previous fiscal year to higher sales and lower profit. - FY2021RestatedAnnual report
「Although selling, general and administrative expenses declined, operating profit fell 32.9% year on year to ¥17,788 million, ordinary profit fell 32.4% to ¥18,222 million, and net profit attributable to owners of the parent fell 30.8% to ¥13,405 million due to lower net sales.」
Operating profit, ordinary profit and net profit attributable to owners of the parent all fell below the same period of the previous year, confirming a decline in profit for the full fiscal year as well. - FY2021-Q3WorsenedAnnual report
「Operating profit declined 33.4% year on year to ¥14,949 million, ordinary profit declined 32.8% to ¥15,347 million, and quarterly net profit attributable to owners of the parent declined 29.7% to ¥10,934 million, mainly due to lower net sales.」
The operating profit decline widened from 28.8% year on year in the previous quarter to 33.4% in the third quarter. Operating profit, ordinary profit and quarterly net profit all fell below the same period of the previous year, and the decline in profit widened. - FY2021-Q2RestatedAnnual report
「The group's performance for the cumulative second-quarter consolidated period was characterized by lower sales and lower profit. Operating profit declined 28.8% year on year to ¥9,782 million, ordinary profit declined 28.1% to ¥10,010 million, and quarterly net profit attributable to owners of the parent declined 24.3% to ¥7,226 million, mainly due to lower net sales.」
As in the previous quarter, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent fell below the same period of the previous year as net sales declined. - FY2021-Q1WorsenedAnnual report
「The group's performance for the cumulative first-quarter consolidated period was characterized by higher sales but lower profit. Operating profit declined 25.0% year on year to ¥5,031 million, ordinary profit declined 23.9% to ¥5,249 million, and quarterly net profit attributable to owners of the parent declined 20.8% to ¥3,820 million, mainly due to lower net sales.」
Although profit had continued to increase in the quarterly reports for the previous fiscal year, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent all fell below the same period of the previous year in the first quarter. - FY2020-Q3RestatedAnnual report
「Although net sales declined, operating profit rose 12.7% year on year to ¥22,432 million due to lower selling, general and administrative expenses. The main reason for the decrease in selling, general and administrative expenses was that research and development expenses fell to ¥4,741 million (down 38.8% year on year). Ordinary profit was ¥22,829 million (up 12.7%), and quarterly net profit attributable to owners of the parent was ¥15,554 million (up 9.2%).」
Although net sales declined, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent all exceeded the same period of the previous year due to lower selling, general and administrative expenses. - FY2020-Q2RestatedAnnual report
「Although net sales declined, operating profit rose 11.2% year on year to ¥13,744 million due to lower selling, general and administrative expenses.」
Although net sales declined, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent all exceeded the same period of the previous year due to lower selling, general and administrative expenses. - FY2020-Q1SoftenedAnnual report
「Although net sales declined, operating profit rose 18.7% year on year to ¥6,705 million due to lower selling, general and administrative expenses. The main reason for the decrease in selling, general and administrative expenses was that research and development expenses fell to ¥1,609 million (down 55.0% year on year). Ordinary profit was ¥6,898 million (up 18.6%), and quarterly net profit attributable to owners of the parent was ¥4,826 million (up 19.6%).」
Operating profit, ordinary profit and quarterly net profit attributable to owners of the parent, which had continued to decline year on year through the previous fiscal year, all increased in the first quarter. - FY2019RestatedAnnual report
「Operating profit was ¥24,592 million (down 10.6% year on year), ordinary profit was ¥24,972 million (down 10.3%), and net profit attributable to owners of the parent was ¥17,775 million (down 6.7%).」
For the full fiscal year, operating profit, ordinary profit and net profit attributable to owners of the parent also fell below the same period of the previous year. - FY2019-Q3RestatedAnnual report
「Although the cost-of-sales ratio was in line with the previous year, operating profit declined 16.0% year on year to ¥19,903 million due to lower net sales and higher selling, general and administrative expenses. Ordinary profit was ¥20,254 million (down 15.8% year on year), and quarterly net profit attributable to owners of the parent was ¥14,247 million (down 15.5%).」
In the cumulative third-quarter consolidated period, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent also fell below the same period of the previous year. - FY2019-Q2RestatedAnnual report
「Although the cost-of-sales ratio was in line with the previous year, operating profit declined 19.4% year on year to ¥12,356 million due to lower net sales and higher selling, general and administrative expenses. Ordinary profit was ¥12,536 million (down 19.2% year on year), and quarterly net profit attributable to owners of the parent was ¥8,840 million (down 18.7%).」
In the cumulative second-quarter consolidated period, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent also fell below the same period of the previous year. - FY2019-Q1First statedAnnual report
「For the cumulative first-quarter consolidated period, the group reported net sales of ¥24,135 million (down 3.3% year on year), operating profit of ¥5,647 million (down 26.2%), ordinary profit of ¥5,817 million (down 25.6%), and quarterly net profit attributable to owners of the parent of ¥4,035 million (down 26.1%).」
In the first quarter, net sales, operating profit, ordinary profit and quarterly net profit attributable to owners of the parent all fell below the same quarter of the previous year.